Skip to main content

Zomedica Corp.

ZOMDF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001684144

No open-market purchases or sales by Zomedica Corp. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $9.50K in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Zomedica Corp. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of ZOMDF: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders97−2
Shares1.78M1.24M−542.1K (−30.4%)
Value$140.5K$126.1K−$14.4K (−10.3%)

New holders (1)

Institutions that held Zomedica Corp. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to ZOMDF in Q4 2025
InstitutionSharesValue% of portfolio
EverSource Wealth Advisors, LLC10$10.00%

Sold out (3)

Institutions that held Zomedica Corp. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of ZOMDF in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Hantz Financial Services, Inc.7,612$1.00K
Cary Street Partners Financial LLC11,300$892
Rossby Financial, LCC100$8